Predicting factors for omitting beta-blockers in patients with tachycardia-induced cardiomyopathy after successful
Aiko Takami1, Masaru Kato2, Yasuhito Kotake1
1Department of Cardiovascular Medicine and Endocrinology and Metabolism, Faculty of Medicine, Tottori University, 36-1 Nishi-Cho, Yonago, 683-8504, Japan.
Tachycardia-induced cardiomyopathy (TIC) patients who underwent successful atrial fibrillation (AF) ablation showed improved left ventricular ejection fraction (LVEF). Beta-blockers may not be necessary post-ablation for select TIC patients, simplifying treatment.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Tachycardia-induced cardiomyopathy (TIC) reduces left ventricular ejection fraction (LVEF).
- Catheter ablation for atrial fibrillation (AF) can improve LVEF in TIC patients.
- The role of beta-blockers in TIC post-ablation is unclear.
Purpose of the Study:
- To evaluate the necessity of beta-blockers for cardiac function in TIC patients after successful AF catheter ablation.
- To identify predictors for discontinuing beta-blockers in TIC patients post-ablation.
Main Methods:
- Retrospective analysis of 124 patients with LVEF ≤50% undergoing AF ablation.
- TIC defined by LVEF improvement ≥10% and reaching ≥50% at 6 months post-ablation.
- Comparison of echocardiographic parameters between patients with and without post-ablation beta-blockers.
Main Results:
- LVEF significantly improved in all 80 TIC patients post-ablation.
- No significant differences in LVEF improvement were observed between patients with and without post-ablation beta-blockers.
- A predictive score identified patients not requiring post-ablation beta-blockers.
Conclusions:
- Successful AF catheter ablation improves LVEF in TIC patients.
- Beta-blockers may not be essential post-ablation for specific TIC patients without other cardiac conditions.
- A simple clinical score can guide de-escalation of beta-blocker therapy.
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: β-Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...


